Search
for
Did you mean SALT Score?
Sort by
Research 30 of 1000+
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial
- Management of Alopecia Areata through Unani Medicine
- Evaluation of the effect of topical calcipotriol versus platelet-rich plasma versus a combination of both on patients with Alopecia Areata
- SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
- Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Etiopathogenesis of Alopecia Areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- EVALUATION OF THE EFFICACY OF PIX LIQUIDA FOR ALOPECIA AREATA: A CASE REPORT
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Alopecia areata: An update
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Alopecia areata: A review
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Response of alopecia areata of the beard to oral tofacitinib
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial